• Reliable, reproducible, easy testing - why wait days to get results?
    The GeneDisc Rapid Microbiology System helps to provide microbial test data in as little as two hours, using a simple to use, robust and cost effective platform based on quantitative Polymerase Chain Reaction (qPCR) technology. Using the GeneDisc Rapid Microbiology System represents an attractive alternative to existing microbiological methods.

  • CoreRx offers diversified technical resources, capacity, flexibility, and experience to manufacture and provide pharmaceutical packaging services with strict quality compliance. Our manufacturing capabilities currently support a variety of dosage forms, with the scale to support Phase I – niche commercial manufacturing.  Our facility design, licenses, and controls allow CoreRx to support manufacturing of DEA scheduled CII – V substances as well as high potency compounds.

  • The SP Hull LyoStar 4.0 designed and built to enhance speed to market of biopharmaceutical products and represents a significant advancement in freeze dryer engineering. Based on a full-scale production freeze dryer to support rapid-scale-up, LyoStar 4.0 is a pilot-scale lyophilizer offering superior shelf mapping, rapid shelf freezing, unmatched process accuracy and reliability. It also includes a cutting-edge suite of Process Analytical Technology (PAT) tools augmenting SP's Line of Sight™ suite of technologies which overcomes critical lyophilization challenges during development, scale‑up and manufacturing of a biologic.

  • According to recent market surveys the global blister packaging market reached a value of US$ 22.7 Billion in 2021. Looking forward, the market to reach US$ 32.2 Billion by 2027, exhibiting a CAGR of 5.8% during 2022-2027.